RenoTact®

Early Detection of Peritonitis

Peritoneal Dialysis (PD) patients are at risk of peritonitis, a severe infection that can lead to treatment failure and increased mortality. Current detection methods rely on measuring a host response and slow culture methods, delaying potentially life-saving interventions.
Results available within 0 Seconds
Peritoneal Dialysis

Chronic Kidney Disease is a worldwide public health problem

Worldwide use of Renal Replacement Therapy (RRT) is projected to more than double to 5.4 million people by 2030.

Current estimates suggest that more than 500,000 patients will receive peritoneal dialysis by 2027, representing approximately 11% of the dialysis population.

With so many people suffering from end-stage renal disease, the demand for diagnostic tools to rapidly identify PD-related infections, is growing fast.

Our Solution

Pexels Jjagtenberg 103127
RenoTact®

Peace of Mind with Early Detection

RenoTact® is a rapid, user-friendly test that directly detects causative agents of peritonitis in PD patients. By enabling earlier medical diagnosis and intervention than standard of care methods, RenoTact® provides a tool to support patients to continue peritoneal dialysis (PD) without transitioning to hemodialysis (HD), preserving their quality of life and treatment independence.

How RenoTact® works

PD Bag
Collect

No Sample Prep

Add a small sample of the PD waste fluid to the VIPER® assay tube containing the RenoTact® assay
2025 03 26 DetactDiagnostics CasperMaas CMA9022
Read

Reader Agnostic

Place the VIPER® assay tube containing the sample, into the DeNIRO® mini Fluorometer (point-of-care) or plate reader (lab-based testing)
Roberto Sorin RS0 H PyByk Unsplash
Treat

Actionable Results

RenoTact® provides actionable data within minutes enabling health care professionals to start immediate targeted treatment

Benefits to healthcare providers

Easy to Obtain Sample

Requires only a small volume (100 µL) sample from the peritoneal dialysis waste fluid

Immediate Result

RenoTact® rapidly identifies viable PD-related Peritonitis infections

Improved Quality of Life for Patient

Reduces risk of treatment failure and ensures continuous preferred PD-treatment

Reduces Hospital Admissions

Provides clinicians actionable data to shorten the time to diagnosis and treatment initiation, decreasing emergency interventions

Our Point-of-Care NIR Fluorometer

Screenshot 2025 04 02 At 15.03.06

Breakthrough Technology – The VIPER® platform detects active infections with accuracy and speed

VIPER® Technology

Other VIPER® Applications

Allergies
SynoTact®
Rapid Detection of Periprosthetic Joint Infections
Peritonitis
MycoTact®
Rapid Detection of Tuberculosis Infection
Syphilis
SpiroTact®
Rapid Detection of Syphilis Infection
Tuberculosis
EnzoTact®
Preventing Milk Spoilage with rapid Protease Detection

RenoTact® is currently for research use only and is not for use in diagnostic procedures; the performance characteristics of this product have yet to be established